Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              12-month Effectiveness and Tolerability of Brivaracetam in Patients with Epilepsy and Cognitive or Psychiatric Comorbidities: Subgroup Data from the International EXPERIENCE Pooled Analysis

              Author:Villanueva, Vicente   D'Souza, Wendyl   Faught, Edward   Klein, Pavel   Reuber, Markus   Rosenow, Felix   Salas-Puig, Javier   Soto Insuga, Victor   Strzelczyk, Adam   Szaflarski, Jerzy P.   Besson, Herve   Bourikas, Dimitrios   Daniels, Tony   Floricel, Florin   Friesen, David   Laloyaux, Cedric   Sendersky, Veronica   Steinhoff, Bernhard J.   

              Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials and Outcomes  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P8.009  

              Author Institution:Hospital Universitario y Politecnico La Fe, Valencia, Spain  The University of Melbourne, Melbourne, Australia  Emory University School of Medicine, Atlanta, GA  Mid-atlantic Epilepsy and Sleep Center, Bethesda, MD  The University of Sheffield, Sheffield, United Kingdom  Epilepsy Center Frankfurt Rhine-Main, Frankfurt am Main, Germany  Universitari Vall d'Hebron, Barcelona, Spain  Hospital Universitario Infantil Nino Jesus, Madrid, Spain  Epilepsy Center Frankfurt Rhine-Main, Frankfurt, Germany  UAB Epilepsy Center, Birmingham, AL  UCB Pharma, Breda, Netherlands  UCB Pharma, Alimos, Greece  UCB Pharma, Morrisville, NC  UCB Pharma, Monheim am Rhein, Germany  UCB Pharma, Slough, United Kingdom  UCB Pharma, Brussels, Belgium  University of Freiburg, Freiburg, Germany